Equitop Myoplast Extends Sponsorship Of The Equerry Bolesworth International Horse Show
7 years ago 
1090 views
Equitop Myoplast, the market leading veterinary supplement which supports lean muscle growth in horses, has extended its sponsorship of the Equerry Bolesworth International Horse Show by taking title sponsorship of the CDI*** Freestyle international dressage competition.
Equitop Myoplast will also continue to sponsor the show-stopping Puissance at the five-day event which takes place from the 14th to 18th June in the stunning grounds of Bolesworth Castle near Tattenhall, Chester. There will be a stellar line up of riders participating in both the Equitop Myoplast Puissance and the Equitop Myoplast CDI*** Freestyle international dressage competition including Carl Hester and Richard Davison, who is sponsored by Equitop Myoplast.
“The Equerry Bolesworth International Horse Show is a popular event which attracts some of the UK’s top riders and trainers,” comments Liz Barrett, business manager for Equitop Myoplast. “We are delighted to be sponsoring both the Equitop Myoplast Puissance and the Equitop Myoplast CDI*** Freestyle international dressage competition. Equitop Myoplast is relevant to both showjumpers and dressage horses in terms of supporting lean muscle growth through the demands of competition and training, so we are delighted to take the title of both classes."
Leading riders use Equitop Myoplast including international showjumpers Scott Brash, Nicole Pavitt, Trevor Breen, Corinne Collins, William Whitaker and Joe Davison.
Equitop Myoplast has been designed with the aim of helping horses respond to the demands of training and rehabilitation and support them though any periods of rest and rehabilitation. It is a unique amino acid supplement which provides horses with the building blocks needed for lean muscle growth.
It is recommended by veterinary surgeons and is the number one equine supplement sold by veterinary practices and pharmacies in the UK1. It is also available from trade outlets and equestrian retailers.
For information on Equitop Myoplast go to www.equitop-myoplast.co.uk or www.facebook.com/equitopmyoplast.
More from Boehringer Ingelheim
- Boehringer Ingelheim receives FDA approval for SENVELGO® (velagliflozin oral solution): the first oral liquid medication for diabetes in cats
- Boehringer Ingelheim Animal Health launches new ProZinc webinar and toolkit
- NexGard Spectra ‘Yum and Done’ competition winner announced
- Boehringer Ingelheim launches Parassess - a “first-of-its-kind”, online, personalised dog parasite risk checker
- ABCD & Boehringer Ingelheim invite applications for the 2022 Young Scientist Award